#METABOLOMICS WORKBENCH cwalker_bcm_20200124_130952 DATATRACK_ID:1908 STUDY_ID:ST001313 ANALYSIS_ID:AN002187 PROJECT_ID:PR000892
VERSION             	1
CREATED_ON             	February 2, 2020, 7:24 pm
#PROJECT
PR:PROJECT_TITLE                 	Lipidomic profiling after early-life exposure to an endocrine disrupting
PR:PROJECT_TITLE                 	chemical in serum after Western Diet challenge.
PR:PROJECT_TYPE                  	Untargeted MS analysis
PR:PROJECT_SUMMARY               	Lipidomic profiling in serum after early-life exposure to an endocrine
PR:PROJECT_SUMMARY               	disrupting chemical under a Western Diet.
PR:INSTITUTE                     	Baylor College of Medicine
PR:LAST_NAME                     	Walker
PR:FIRST_NAME                    	Cheryl
PR:ADDRESS                       	1 Baylor Plaza, Houston, TX, 77030, USA
PR:EMAIL                         	Cheryl.walker@bcm.edu
PR:PHONE                         	713-798-8219
#STUDY
ST:STUDY_TITLE                   	Lipid expression in serum after early life exposure to an endocrine disruptor
ST:STUDY_TITLE                   	and a Western Diet at 240 days postnatal (part-IV)
ST:STUDY_TYPE                    	Lipid expression after chemical exposure versus control
ST:STUDY_SUMMARY                 	Our early-life environment has a profound influence on developing organs that
ST:STUDY_SUMMARY                 	impact metabolic function and determines disease susceptibility across the
ST:STUDY_SUMMARY                 	life-course. Using a rat model for exposure to an endocrine disrupting chemical
ST:STUDY_SUMMARY                 	(EDC), we show that early-life exposure causes metabolic dysfunction in
ST:STUDY_SUMMARY                 	adulthood and reprograms histone marks in the developing liver to accelerate
ST:STUDY_SUMMARY                 	acquisition of an adult epigenomic signature. This epigenomic reprogramming
ST:STUDY_SUMMARY                 	persists long after the initial exposure, but many reprogrammed genes remain
ST:STUDY_SUMMARY                 	transcriptionally silent with their impact on metabolism not revealed until a
ST:STUDY_SUMMARY                 	later life exposure to a Western-style diet. Diet-dependent metabolic disruption
ST:STUDY_SUMMARY                 	was largely driven by reprogramming of the Early Growth Response 1 (EGR1)
ST:STUDY_SUMMARY                 	transcriptome and production of metabolites in pathways linked to cholesterol,
ST:STUDY_SUMMARY                 	lipid and one-carbon metabolism. These findings demonstrate the importance of
ST:STUDY_SUMMARY                 	epigenome:environment interactions, which early in life accelerate epigenomic
ST:STUDY_SUMMARY                 	aging, and later in adulthood unlock metabolically restricted epigenetic
ST:STUDY_SUMMARY                 	reprogramming to drive metabolic dysfunction.
ST:INSTITUTE                     	Baylor College of Medicine
ST:LAST_NAME                     	Walker
ST:FIRST_NAME                    	Cheryl
ST:ADDRESS                       	1 Baylor Plaza, Houston, TX, 77030, USA
ST:EMAIL                         	Cheryl.walker@bcm.edu
ST:PHONE                         	713-798-8219
ST:NUM_GROUPS                    	2
ST:TOTAL_SUBJECTS                	10
ST:NUM_MALES                     	10
#SUBJECT
SU:SUBJECT_TYPE                  	Mammal
SU:SUBJECT_SPECIES               	Rattus norvegicus
SU:TAXONOMY_ID                   	10116
SU:GENOTYPE_STRAIN               	Sprague Dawley
SU:AGE_OR_AGE_RANGE              	240 days
SU:GENDER                        	Male
SU:ANIMAL_ANIMAL_SUPPLIER        	Harlan
SU:ANIMAL_HOUSING                	polycarbonate-free caging
SU:ANIMAL_LIGHT_CYCLE            	14-hr light and 10-hr dark
SU:ANIMAL_FEED                   	Phytoestrogen Reduced II 18-5 (Ziegler Bros, Inc) or D09100301 (Research Diets,
SU:ANIMAL_FEED                   	Inc)
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	HFB1	Treatment:BPA	Day of Serum Harvest Post-Birth=240; BPA_exposure=50 ug/kg post natal days 1, 3, and 5; Diet=phytoestrogen-reduced a diet for first 180 days post birth then diet high in fat (40% kcal), fructose (20% kcal) and cholesterol (2%) (Western-style diet) for 60 days.
SUBJECT_SAMPLE_FACTORS           	-	HFB2	Treatment:BPA	Day of Serum Harvest Post-Birth=240; BPA_exposure=50 ug/kg post natal days 1, 3, and 5; Diet=phytoestrogen-reduced a diet for first 180 days post birth then diet high in fat (40% kcal), fructose (20% kcal) and cholesterol (2%) (Western-style diet) for 60 days.
SUBJECT_SAMPLE_FACTORS           	-	HFB3	Treatment:BPA	Day of Serum Harvest Post-Birth=240; BPA_exposure=50 ug/kg post natal days 1, 3, and 5; Diet=phytoestrogen-reduced a diet for first 180 days post birth then diet high in fat (40% kcal), fructose (20% kcal) and cholesterol (2%) (Western-style diet) for 60 days.
SUBJECT_SAMPLE_FACTORS           	-	HFB4	Treatment:BPA	Day of Serum Harvest Post-Birth=240; BPA_exposure=50 ug/kg post natal days 1, 3, and 5; Diet=phytoestrogen-reduced a diet for first 180 days post birth then diet high in fat (40% kcal), fructose (20% kcal) and cholesterol (2%) (Western-style diet) for 60 days.
SUBJECT_SAMPLE_FACTORS           	-	HFB5	Treatment:BPA	Day of Serum Harvest Post-Birth=240; BPA_exposure=50 ug/kg post natal days 1, 3, and 5; Diet=phytoestrogen-reduced a diet for first 180 days post birth then diet high in fat (40% kcal), fructose (20% kcal) and cholesterol (2%) (Western-style diet) for 60 days.
SUBJECT_SAMPLE_FACTORS           	-	HFV1	Treatment:vehicle	Day of Serum Harvest Post-Birth=240; BPA_exposure=0 ug/kg post natal days 1, 3, and 5; Diet=phytoestrogen-reduced a diet for first 180 days post birth then diet high in fat (40% kcal), fructose (20% kcal) and cholesterol (2%) (Western-style diet) for 60 days.
SUBJECT_SAMPLE_FACTORS           	-	HFV2	Treatment:vehicle	Day of Serum Harvest Post-Birth=240; BPA_exposure=0 ug/kg post natal days 1, 3, and 5; Diet=phytoestrogen-reduced a diet for first 180 days post birth then diet high in fat (40% kcal), fructose (20% kcal) and cholesterol (2%) (Western-style diet) for 60 days.
SUBJECT_SAMPLE_FACTORS           	-	HFV3	Treatment:vehicle	Day of Serum Harvest Post-Birth=240; BPA_exposure=0 ug/kg post natal days 1, 3, and 5; Diet=phytoestrogen-reduced a diet for first 180 days post birth then diet high in fat (40% kcal), fructose (20% kcal) and cholesterol (2%) (Western-style diet) for 60 days.
SUBJECT_SAMPLE_FACTORS           	-	HFV4	Treatment:vehicle	Day of Serum Harvest Post-Birth=240; BPA_exposure=0 ug/kg post natal days 1, 3, and 5; Diet=phytoestrogen-reduced a diet for first 180 days post birth then diet high in fat (40% kcal), fructose (20% kcal) and cholesterol (2%) (Western-style diet) for 60 days.
SUBJECT_SAMPLE_FACTORS           	-	HFV5	Treatment:vehicle	Day of Serum Harvest Post-Birth=240; BPA_exposure=0 ug/kg post natal days 1, 3, and 5; Diet=phytoestrogen-reduced a diet for first 180 days post birth then diet high in fat (40% kcal), fructose (20% kcal) and cholesterol (2%) (Western-style diet) for 60 days.
#COLLECTION
CO:COLLECTION_SUMMARY            	Blood was collected via cardiac puncture at the time of tissue harvest. For
CO:COLLECTION_SUMMARY            	separating serum from the blood cells, the samples were allowed to clot at room
CO:COLLECTION_SUMMARY            	temperature for 20-30 minutes, followed by centrifugation for 10 min at 1000 x
CO:COLLECTION_SUMMARY            	g, and storage of the separated serum at -80°C.
CO:SAMPLE_TYPE                   	Blood (serum)
#TREATMENT
TR:TREATMENT_SUMMARY             	Neonatal rats were treated with vehicle (sesame oil) or bisphenol A (BPA; 50
TR:TREATMENT_SUMMARY             	µg/kg dissolved in sesame oil) orally via pipette tip on post-natal days 1, 3,
TR:TREATMENT_SUMMARY             	and 5. Littermates were randomly assigned to the treatment groups. BPA was
TR:TREATMENT_SUMMARY             	obtained from the National Institute of Environmental Health Sciences (NIEHS).
TR:TREATMENT_SUMMARY             	The dose and route of administration recapitulates human exposure to BPA. At day
TR:TREATMENT_SUMMARY             	180, adult rats in both treatment groups were fed a diet high in fat (40% kcal),
TR:TREATMENT_SUMMARY             	fructose (20% kcal) and cholesterol (2%) (Western-style diet) for 60 days
TR:TREATMENT_SUMMARY             	(D09100301, Research Diets, Inc). Rats were fasted overnight prior to tissue
TR:TREATMENT_SUMMARY             	collection.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Lipids were extracted using a modified Bligh-Dyer method. Fifty µL of serum and
SP:SAMPLEPREP_SUMMARY            	25 mg of crushed liver was used for the extraction. The extraction was carried
SP:SAMPLEPREP_SUMMARY            	out using 2:2:2 volume ratio of water/methanol/dichloromethane at room
SP:SAMPLEPREP_SUMMARY            	temperature after spiking internal standards 17:0 LPC, 17:0 PC, 17:0 PE, 17:0
SP:SAMPLEPREP_SUMMARY            	PG, 17:0 ceramide, 17:0 SM, 17:0PS, 17:0PA, 17:0 TAG, 17:0 MAG, 16:0/18:1 DAG,
SP:SAMPLEPREP_SUMMARY            	17:0 CE. The organic layer was collected and completely dried under nitrogen.
SP:SAMPLEPREP_SUMMARY            	Before MS analysis, the dried extract was resuspended in 100 μL of Buffer B
SP:SAMPLEPREP_SUMMARY            	(10:5:85 Acetonitrile/water/Isopropyl alcohol) containing 10 mM NH4OAc and
SP:SAMPLEPREP_SUMMARY            	subjected to LC/MS. The lipidome was separated using reverse-phase
SP:SAMPLEPREP_SUMMARY            	chromatography.
SP:SAMPLEPREP_PROTOCOL_FILENAME  	unbiased.serum.MS.method.pdf
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Shimadzu Nexera-x2
CH:COLUMN_NAME                   	Acquity HSS UPLC T3 column (1.8 µm particle 50 × 2.1 mm)
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	ABI Sciex 5600 TripleTOF
MS:INSTRUMENT_TYPE               	QTOF
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	NEGATIVE
MS:MS_COMMENTS                   	For data acquisition through LC/MS analysis, we used a Shimadzu CTO-20A Nexera
MS:MS_COMMENTS                   	X2 UHPLC system equipped with a degasser, binary pump, thermostatted auto
MS:MS_COMMENTS                   	sampler, and a column oven for chromatographic separation. The column heater
MS:MS_COMMENTS                   	temperature was set at 55°C. For lipid separation, the 5 uL of the lipid
MS:MS_COMMENTS                   	extract was injected into a 1.8 μm particle 50 × 2.1 mm Acquity HSS UPLC T3
MS:MS_COMMENTS                   	column (Waters, Milford, MA) which heats to 55°C. Acetonitrile/water (40:60,
MS:MS_COMMENTS                   	v/v) with 10 mM ammonium acetate was solvent A and
MS:MS_COMMENTS                   	acetonitrile/water/isopropanol (10:5:85 v/v) with 10 mM ammonium acetate was
MS:MS_COMMENTS                   	solvent B. For chromatographic elution we used a linear gradient over a 20 min
MS:MS_COMMENTS                   	total run time, with 60% solvent A and 40% solvent B gradient in the first 10
MS:MS_COMMENTS                   	minutes, then the gradient was ramped in a linear fashion to 100% solvent B
MS:MS_COMMENTS                   	which was maintained for 7 minutes. After that the system was switched back to
MS:MS_COMMENTS                   	60% solvent B and 40% solvent A for 3 minutes. The flow rate used for these
MS:MS_COMMENTS                   	experiments was 0.4 mL/min and the injection volume was 5μL. The column was
MS:MS_COMMENTS                   	equilibrated for 3 min before the next injection and run at a flow rate of 0.4
MS:MS_COMMENTS                   	mL/min for a total run time of 20 min. The data acquisition of each sample was
MS:MS_COMMENTS                   	performed in both positive and negative ionization modes using a TripleTOF 5600
MS:MS_COMMENTS                   	equipped with a Turbo VTM ion source (AB Sciex, Concord, Canada). The column
MS:MS_COMMENTS                   	effluent was directed to the electrospray ionization source. The voltage of
MS:MS_COMMENTS                   	source was set to 5500 V for positive ionization and 4500 V for negative
MS:MS_COMMENTS                   	ionization mode, the declustering potential was set to 60 V, and the source
MS:MS_COMMENTS                   	temperature to 450oC for both modes. The curtain gas flow, nebulizer, and heater
MS:MS_COMMENTS                   	gas were set to 30, 40, and 45 units, respectively. The instrument performed one
MS:MS_COMMENTS                   	TOF MS survey scan (150 ms) and 15 MS/MS scans with a total duty cycle time of
MS:MS_COMMENTS                   	2.4 s. The mass range in both modes was 50-1200 m/z. We controlled the
MS:MS_COMMENTS                   	acquisition of MS/MS spectra by data-dependent acquisition (DDA) function of the
MS:MS_COMMENTS                   	Analyst TF software (AB Sciex, Concord, Canada) with the following parameters:
MS:MS_COMMENTS                   	dynamic background subtraction, charge monitoring to exclude multiply charged
MS:MS_COMMENTS                   	ions and isotopes, and dynamic exclusion of former target ions for 9 s. Rolling
MS:MS_COMMENTS                   	collision energy spread was set whereby the software calculated the collision
MS:MS_COMMENTS                   	energy value to be applied as a function of m/z. Mass accuracy was maintained by
MS:MS_COMMENTS                   	the use of an automated calibrant delivery system interfaced to the second inlet
MS:MS_COMMENTS                   	of the DuoSpray source.
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS	peak intensity
MS_METABOLITE_DATA_START
Samples	HFB1	HFB2	HFB3	HFB4	HFB5	HFV1	HFV2	HFV3	HFV4	HFV5
Factors	Treatment:BPA	Treatment:BPA	Treatment:BPA	Treatment:BPA	Treatment:BPA	Treatment:vehicle	Treatment:vehicle	Treatment:vehicle	Treatment:vehicle	Treatment:vehicle
PS 38:4; [M-H]-; GPSer(18:0/20:4(5E,8E,11E,14E))	2606	2677	411	551	326	734	417	1083	110	135
PE 36:0; [M-H]-; GPEtn(17:0/19:0)	10936	10079	12899	10941	11829	10538	10062	8052	9438	8592
PE 40:6; [M-H]-; GPEtn(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	9771	14934	11054	13004	8229	16437	19273	16986	12556	14712
PE 38:6; [M-H]-; GPEtn(18:2(2E,4E)/20:4(5E,8E,11E,14E))	359549	591606	428839	210578	359634	175190	77153	168329	196110	144314
PS 40:6; [M-H]-; GPSer(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	316	455	650	220	178	140	160	141	98	405
PE 25:0; [M-H]-; GPEtn(7:0/18:0)	168	160	113	197	169	169	61	165	343	223
PE 21:0; [M-H]-; GPEtn(5:0/16:0)	139	115	137	77	161	178	161	148	93	184
PG 36:0; [M-H]-; GPGro(17:0/19:0)	16879	16091	22598	13696	17606	24155	17564	20268	21872	23132
PE 40:7; [M-H]-; GPEtn(18:1(11E)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	22928	36656	23493	22738	22607	18464	8177	18369	12515	17508
PE 40:4; [M-H]-; GPEtn(20:0/20:4(5E,8E,11E,14E))	3259	5527	3825	966	2702	1514	789	518	1963	392
CL 70:5; [M-2H](2-); CL(18:1/16:0/18:2/18:2)	56510	55376	64969	44527	63371	41797	34990	34202	44837	31866
PE 23:0; [M-H]-; GPEtn(7:0/16:0)	646	281	262	870	512	559	421	570	367	224
PE 38:6; [M-H]-; GPEtn(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	358386	602271	432690	224920	357861	184992	79526	174813	197952	157942
CL 70:5; [M-2H](2-); CL(18:1/16:1/18:1/18:2)	78396	55445	71758	20963	51786	18126	16564	12648	27390	12743
PE 40:2; [M-H]-; GPEtn(18:0/22:2(13Z,16Z))	47	89	97	62	107	93	23	49	26	33
PE 38:5; [M-H]-; GPEtn(18:0/20:5(5Z,8Z,11Z,14Z,17Z))	473402	663965	586517	312820	466104	313753	165734	288409	279210	264403
PE 38:2; [M-H]-; GPEtn(18:2(2E,4E)/20:0)	4732	5667	4704	4200	5640	2463	1731	3725	3925	2347
PE 33:0; [M-H]-; GPEtn(16:0/17:0)	951	1271	1701	1782	1993	2116	1824	2539	1915	2161
MGDG 34:0; [M-H]-; MGDG(16:0/18:0)	42	3009	117	322	62	155	85	144	182	128
PE 40:2; [M-H]-; GPEtn(18:1(11E)/22:1(13Z))	443	374	438	207	402	263	146	335	395	403
PE 42:10; [M-H]-; GPEtn(20:4(5E,8E,11E,14E)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	2669	3607	4691	884	2560	643	154	910	1536	782
PE 36:0; [M-H]-; GPEtn(16:0/20:0)	131	113	122	101	77	66	53	31	45	32
PE 38:2; [M-H]-; GPEtn(18:1(11E)/20:1(11E))	4936	5586	5063	3311	5477	2389	1686	3620	4044	2357
PS 38:5; [M-H]-; GPSer(18:1(11E)/20:4(5E,8E,11E,14E))	312	410	375	312	456	204	100	573	402	205
CL 72:6; [M-2H](2-); CL(18:1/18:2/18:2/18:1)	183	52	48	162	185	21	124	108	217	166
PC 40:6; [M-CH3]-; GPCho(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	2918	3477	1951	1216	1919	965	1506	467	2264	1050
PE 24:0; [M-H]-; GPEtn(6:0/18:0)	1287	1028	564	329	645	625	1039	796	399	1073
PE 23:0; [M-H]-; GPEtn(5:0/18:0)	809	164	106	167	152	316	555	146	165	289
PC 38:6; [M-CH3]-; GPCho(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	153	303	43	104	45	131	123	125	64	65
PE 36:5; [M-H]-; GPEtn(16:0/20:5(5Z,8Z,11Z,14Z,17Z))	7570	8825	10562	5807	7806	11717	10145	11759	10005	8021
PE 40:7; [M-H]-; GPEtn(20:3(5Z,8Z,11Z)/20:4(5E,8E,11E,14E))	86446	117932	81698	32776	73892	25629	7143	32232	36458	25620
PE 34:2; [M-H]-; GPEtn(16:1(7Z)/18:1(11E))	125704	119186	105483	33527	75993	30739	21579	35003	50394	31472
PA 40:7; [M-H]-; GPA(18:1(11E)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	2766	2884	2123	1662	1218	1788	3855	1209	900	1799
PA 34:0; [M-H]-; GPA(17:0/17:0)	3752	3046	8971	2076	3361	19039	5771	2089	5039	7213
PI 36:2; [M-H]-; GPIns(18:0/18:2(2E,4E))	22913	26016	23477	15407	26451	20143	18381	11144	12073	9800
PG 38:6; [M-H]-; GPGro(18:2(2E,4E)/20:4(5E,8E,11E,14E))	23	96	35	71	43	41	85	39	47	80
CL 74:2; [M-2H](2-); CL(18:0/18:1/18:0/20:1)	22767	27630	21679	11568	20897	12236	13322	7792	12711	8968
PG 33:0; [M-H]-; GPGro(17:0/16:0)	7398	9183	10235	5946	8038	11664	9852	11171	10301	8200
PC 34:2; [M-Ac-H]-; GPCho(16:0/18:2(2E,4E))	5566	5578	8029	2981	4676	4012	3900	2370	4788	4344
PE 42:6; [M-H]-; GPEtn(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	407	531	354	113	579	712	222	358	233	811
PE 32:1; [M-H]-; GPEtn(16:0/16:1(7Z))	4655	1714	2509	1626	3076	762	868	1609	1773	856
PE 22:0; [M-H]-; GPEtn(4:0/18:0)	261	40	98	47	337	53	161	123	124	53
PE 38:5; [M-H]-; GPEtn(18:1(11E)/20:4(5E,8E,11E,14E))	6319	7188	7649	3557	4392	897	2340	3436	2127	3715
PG 38:5; [M-H]-; GPGro(18:1(11E)/20:4(5E,8E,11E,14E))	125	153	107	41	73	77	287	65	103	38
PC 36:4; [M-Ac-H]-; GPCho(16:0/20:4(5E,8E,11E,14E))	488672	691865	581696	310079	450298	278908	144610	297741	244957	224054
PG 32:1; [M-H]-; GPGro(16:0/16:1(7Z))	159	131	155	107	40	264	77	105	34	180
PC 34:3; [M-Ac-H]-; GPCho(16:1(7Z)/18:2(2E,4E))	13558	8691	10200	4765	6050	3952	4427	2138	2061	2416
PC 38:4; [M-CH3]-; GPCho(18:0/20:4(5E,8E,11E,14E))	33250	55881	45667	23607	29800	22153	17045	20253	25610	19165
PE 42:3; [M-H]-; GPEtn(18:2(2E,4E)/24:1(15Z))	379	538	286	436	391	339	246	397	252	559
PE 42:7; [M-H]-; GPEtn(20:1(11E)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	536	851	413	1247	1035	1441	1316	1395	887	223
PA 34:2; [M-H]-; GPA(16:0/18:2(2E,4E))	889	1786	813	1170	1136	823	835	264	1313	835
PE 42:2; [M-H]-; GPEtn(18:1(11E)/24:1(15Z))	720	852	372	395	422	944	1328	347	1164	587
CL 72:7; [M-2H](2-); CL(16:0/20:4/18:1/18:2)	428	900	469	259	196	503	177	215	341	447
PC 35:3; [M-Ac-H]-; GPCho(17:1(9Z)/18:2(2E,4E))	17544	14017	11313	5764	10008	6232	2976	6769	5840	5981
PC 38:6; [M-CH3]-; GPCho(18:2(2E,4E)/20:4(5E,8E,11E,14E))	18876	35929	17573	15890	16716	12553	5334	13918	8277	13389
PE 40:6; [M-H]-; GPEtn(18:1(11E)/22:5(4Z,7Z,10Z,13Z,16Z))	167780	345197	221152	105012	148986	100357	42994	97077	125462	74723
PC 21:0; [M-Ac-H]-; GPCho(5:0/16:0)	2445	1245	934	860	983	740	3682	1192	911	1548
PC 32:1; [M-CH3]-; GPCho(16:0/16:1(7Z))	100	157	80	12	13	59	30	30	51	198
PG 38:4; [M-H]-; GPGro(18:1(11E)/20:3(5Z,8Z,11Z))	191	151	484	218	192	337	548	206	306	195
PC 25:0; [M+HCOO]-; GPCho(2:0/23:0)	26194	23359	17542	7936	24223	9784	5066	9516	14710	7228
PG 19:0; [M-H]-; GPGro(2:0/17:0)	248	351	104	169	296	169	160	1131	243	448
PI 38:3; [M-H]-; GPIns(18:0/20:3(5Z,8Z,11Z))	2737	5660	2980	4724	2925	3377	2773	2266	2088	2164
PG 40:7; [M-H]-; GPGro(18:1(11E)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	34	117	36	54	94	353	164	62	138	29
PC 38:0; [M-Ac-H]-; GPCho(16:0/22:0)	308	518	444	529	181	314	130	272	295	103
PI 40:5; [M-H]-; GPIns(18:0/22:5(4Z,7Z,10Z,13Z,16Z))	19633	26314	13287	9728	17141	13793	5864	17101	9614	8549
PE 42:5; [M-H]-; GPEtn(20:4(5E,8E,11E,14E)/22:1(13Z))	1221	614	2818	161	911	775	513	1729	1172	1019
CL 74:7; [M-2H](2-); CL(18:2/20:1/20:4/16:0)	453	365	258	198	104	199	213	146	338	245
PE 38:4; [M-H]-; GPEtn(18:0/20:4(5E,8E,11E,14E))	8827	12458	14124	9502	12093	7165	7058	10016	7255	6848
CL 70:4; [M-2H](2-); CL(16:0/18:1/18:1/18:2)	400	1449	341	187	143	212	399	458	866	562
PE 42:4; [M-H]-; GPEtn(20:4(5E,8E,11E,14E)/22:0)	668	676	382	556	423	503	717	524	438	672
PE 42:7; [M-H]-; GPEtn(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	2408	1994	1025	1158	2059	859	521	2085	993	1463
PC 36:2; [M-Ac-H]-; GPCho(18:0/18:2(2E,4E))	21149	18243	18159	11449	13968	11054	13140	9112	10912	13316
PC 32:1; [M-CH3]-; GPCho(16:1(7Z)/16:0)	20271	20591	20703	9947	13721	10156	8017	8769	12717	8072
CL 74:7; [M-2H](2-); CL(18:1/18:0/18:2/20:4)	552	90	263	166	499	198	99	221	251	97
plasmenyl-PE 36:5; [M-H]-; PE(P-16:0/20:5(5Z,8Z,11Z,14Z,17Z))	3183	1619	4318	1682	3095	2405	1979	1802	1931	1235
PE 36:4; [M-H]-; GPEtn(16:0/20:4(5E,8E,11E,14E))	145269	232692	177409	86451	125655	65328	41820	66824	67680	63292
PE 40:4; [M-H]-; GPEtn(16:0/24:4(5Z,8Z,11Z,14Z))	115	86	35	42	11	67	35	54	68	44
PI 38:4; [M-H]-; GPIns(18:0/20:4(5E,8E,11E,14E))	294557	507474	439975	237025	309494	290135	191604	248632	209453	178370
PE 37:1; [M-H]-; GPEtn(18:1(11E)/19:0)	289	360	776	183	712	347	424	189	312	580
PC 23:0; [M-Ac-H]-; GPCho(5:0/18:0)	2891	1727	1273	1519	1635	2009	1237	1823	1202	1481
PE 30:0; [M-H]-; GPEtn(14:0/16:0)	124	518	595	153	233	193	73	97	200	97
PC 38:2; [M-CH3]-; GPCho(20:1(11E)/18:1(11E))	1361	2412	1445	1027	736	1134	988	865	744	766
PC 34:2; [M+HCOO]-; GPCho(16:1(7Z)/18:1(11E))	842	373	473	805	2552	1139	448	390	479	1132
PC 38:4; [M-Ac-H]-; GPCho(18:0/20:4(5E,8E,11E,14E))	13733	15985	15703	6772	11165	8717	7418	8290	6693	8470
CL 68:3; [M-2H](2-); CL(16:0/16:0/18:1/18:2)	14512	12926	16974	12661	14126	13039	8931	5366	8715	5118
PE 33:2; [M-H]-; GPEtn(15:0/18:2(2E,4E))	3247	2151	2423	652	3005	714	639	843	624	312
PC 34:1; [M-Ac-H]-; GPCho(16:0/18:1(11E))	385027	485714	400854	211686	345119	217426	175822	206256	191683	163143
PC 22:0; [M-Ac-H]-; GPCho(6:0/16:0)	657	855	766	499	538	718	218	385	422	282
PG 34:3; [M-H]-; GPGro(16:1(7Z)/18:2(2E,4E))	101	97	63	100	32	2	1	56	43	45
PE 37:5; [M-H]-; GPEtn(17:1(9Z)/20:4(5E,8E,11E,14E))	7601	6946	9688	2143	6970	4078	4347	2878	6010	3185
CL 68:1; [M-2H](2-); CL(16:0/16:0/18:0/18:1)	2904	4610	3724	2704	1507	2532	1120	639	1247	2685
PC 39:3; [M-Ac-H]-; GPCho(19:0/20:3(5Z,8Z,11Z))	596	515	372	487	670	380	254	636	806	717
PC 38:5; [M-CH3]-; GPCho(18:1(11E)/20:4(5E,8E,11E,14E))	23666	48074	45838	22242	22764	20813	12554	17691	16705	16700
PE 39:4; [M-H]-; GPEtn(19:0/20:4(5E,8E,11E,14E))	1122	2705	2119	2036	2887	535	658	755	2046	1936
PE 40:5; [M-H]-; GPEtn(20:1(11E)/20:4(5E,8E,11E,14E))	32785	65246	34374	22680	29137	24461	12550	20970	24973	18760
PE 40:1; [M-H]-; GPEtn(18:0/22:1(13Z))	356	1237	211	339	372	272	582	217	195	191
plasmenyl-PE 42:6; [M-H]-; PE(P-20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	3895	3806	3839	2027	2741	2020	2744	1439	1825	1341
PE 36:3; [M-H]-; GPEtn(18:1(11E)/18:2(2E,4E))	7904	10410	9234	6264	7141	4729	5508	6679	4795	2789
plasmenyl-PE 38:6; [M-H]-; PE(P-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	4103	3238	4675	3680	3768	3929	4627	3503	2260	4252
PS 40:7; [M-H]-; GPSer(18:1(11E)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	194	377	89	138	104	57	62	22	40	101
PC 22:0; [M+HCOO]-; GPCho(6:0/16:0)	116	180	200	119	156	57	466	98	90	186
PE 38:5; [M-H]-; GPEtn(16:0/22:5(4Z,7Z,10Z,13Z,16Z))	510946	683156	611100	285227	493680	288138	146112	276962	277682	233926
PE 40:5; [M-H]-; GPEtn(18:0/22:5(4Z,7Z,10Z,13Z,16Z))	23780	40396	32960	22403	23864	20268	11989	17233	16093	16008
CL 68:4; [M-2H](2-); CL(16:0/18:2/16:1/18:1)	24590	16517	26834	11265	21533	8138	6172	8635	11618	10179
PC 26:0; [M-CH3]-; GPCho(16:0/10:0)	554	266	368	496	308	230	220	184	303	366
PE 34:3; [M-H]-; GPEtn(16:1(7Z)/18:2(2E,4E))	60081	41293	46262	11619	36723	11549	7233	7296	17917	6455
PE 36:5; [M-H]-; GPEtn(16:1(7Z)/20:4(5E,8E,11E,14E))	84555	83717	77056	30407	64957	28465	15595	17458	33246	18575
PE 38:4; [M-H]-; GPEtn(18:1(11E)/20:3(5Z,8Z,11Z))	18009	28135	25222	15072	18345	15798	12266	13156	13645	12500
PC 27:0; [M+HCOO]-; GPCho(2:0/25:0)	212	160	39	48	58	57	50	140	72	191
PE 35:1; [M-H]-; GPEtn(17:0/18:1(11E))	1067	963	539	684	1070	734	278	104	660	136
PG 36:2; [M-H]-; GPGro(18:0/18:2(2E,4E))	4108	2264	4758	1774	4162	4723	2429	1499	3446	1848
PC 38:6; [M+HCOO]-; GPCho(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	14796	21358	14128	4239	11590	5041	1707	6358	5083	4294
PC 40:3; [M-Ac-H]-; GPCho(20:0/20:3(5Z,8Z,11Z))	908	1618	764	419	394	910	919	504	361	522
CL 72:6; [M-2H](2-); CL(18:1/18:2/18:1/18:2)	11408	7909	8668	4964	4587	7947	9847	2582	5163	8804
PC 42:10; [M-Ac-H]-; GPCho(20:4(5E,8E,11E,14E)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	7437	7145	6533	1926	6545	3264	833	3578	4126	1589
CL 72:2; [M-2H](2-); CL(16:0/20:1/18:0/18:1)	536	871	734	515	594	610	696	351	421	660
CL 72:7; [M-2H](2-); CL(16:0/18:1/18:2/20:4)	875	791	614	307	211	415	318	662	1059	577
PC 35:4; [M+HCOO]-; GPCho(15:0/20:4(5E,8E,11E,14E))	16755	20877	18502	8971	15680	4101	3713	5753	7989	6912
PE 38:7; [M-H]-; GPEtn(16:1(7Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	919	1249	632	176	418	757	556	209	569	191
PC 40:7; [M-CH3]-; GPCho(18:1(11E)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	2421	1443	1771	1753	1986	3798	3043	902	1678	1127
PC 36:4; [M-Ac-H]-; GPCho(18:2(2E,4E)/18:2(2E,4E))	249620	297359	277674	89532	225745	104022	36988	121934	116459	65188
PG 36:2; [M-H]-; GPGro(16:0/20:2(11Z,14Z))	13119	22480	12714	7712	12383	8317	3423	4835	6709	5388
PE 35:3; [M-H]-; GPEtn(17:1(9Z)/18:2(2E,4E))	1037	535	668	291	566	375	458	497	528	204
PA 38:4; [M-H]-; GPA(18:0/20:4(5E,8E,11E,14E))	1923	995	2666	1073	1345	810	1461	1239	1049	1390
PC 30:0; [M-Ac-H]-; GPCho(14:0/16:0)	50410	11908	9691	6196	6047	3789	4306	4129	4131	4979
PC 36:2; [M-CH3]-; GPCho(18:0/18:2(2E,4E))	57442	67346	56886	37706	48361	44184	37706	28810	40769	29062
PC 36:5; [M-Ac-H]-; GPCho(16:1(7Z)/20:4(5E,8E,11E,14E))	2495	3306	2274	1868	3045	831	1857	893	739	2116
DGDG 34:1; [M-H]-; DGDG(16:0/18:1(11E))	62	111	59	147	202	48	112	139	71	165
PE 35:4; [M-H]-; GPEtn(15:0/20:4(5E,8E,11E,14E))	2673	4368	4159	1295	4242	1391	1179	782	1189	696
PC 34:1; [M+HCOO]-; GPCho(16:0/18:1(11E))	6901	9068	8699	3907	9569	4260	3135	4831	5051	3449
PG 40:6; [M-H]-; GPGro(18:1(11E)/22:5(4Z,7Z,10Z,13Z,16Z))	1238	3546	1151	430	837	940	463	1030	564	784
DGDG 36:3; [M-H]-; DGDG(18:1(11E)/18:2(2E,4E))	170	257	162	138	226	134	104	284	182	82
MGDG 39:6; [M-H]-; MGDG(17:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	2849	1748	3395	2544	1159	1655	459	2921	1251	1235
PS 40:4; [M-H]-; GPSer(18:0/22:4(7Z,10Z,13Z,16Z))	212	409	469	183	432	381	349	4827	322	8813
PC 38:6; [M-Ac-H]-; GPCho(18:2(2E,4E)/20:4(5E,8E,11E,14E))	98830	161803	101431	29209	80281	34356	15074	39250	39639	31083
PE 37:4; [M-H]-; GPEtn(17:0/20:4(5E,8E,11E,14E))	10186	18197	11525	5728	9711	6008	2990	4289	4112	4468
PC 36:0; [M-Ac-H]-; GPCho(16:0/20:0)	195	332	251	37	173	206	167	76	321	171
PE 44:5; [M-H]-; GPEtn(20:4(5E,8E,11E,14E)/24:1(15Z))	889	2487	1155	617	1295	455	362	591	1088	750
CL 70:5; [M-2H](2-); CL(18:2/18:0/18:3/16:0)	79510	59445	78190	23626	51889	19529	18979	11724	26730	14757
PC 24:0; [M-Ac-H]-; GPCho(6:0/18:0)	164	174	201	155	120	223	145	184	163	314
PE 36:5; [M-H]-; GPEtn(18:2(2E,4E)/18:3(6Z,9Z,12Z))	51487	44651	45095	8115	33397	12243	4360	9479	19605	6711
PE 39:3; [M-H]-; GPEtn(19:0/20:3(5Z,8Z,11Z))	465	568	735	427	354	318	483	530	360	132
PC 38:3; [M-CH3]-; GPCho(18:0/20:3(5Z,8Z,11Z))	8074	8866	5863	5271	5765	6981	3600	7016	4170	5208
PC 35:2; [M-CH3]-; GPCho(17:0/18:2(2E,4E))	690	1025	1125	1168	637	670	377	370	783	533
PC 36:4; [M-CH3]-; GPCho(16:0/20:4(5E,8E,11E,14E))	4326	7398	8303	3605	3681	3549	2848	3152	2136	3935
MGDG 40:6; [M-H]-; MGDG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	130	353	128	54	81	33	125	180	77	41
PC 32:0; [M-Ac-H]-; GPCho(15:0/17:0)	2459	3417	2721	2050	1743	1728	3154	1491	1356	2264
PE 41:4; [M-H]-; GPEtn(19:0/22:4(7Z,10Z,13Z,16Z))	722	1797	366	182	542	668	289	1124	211	531
PC 40:3; [M-Ac-H]-; GPCho(18:1(11E)/22:2(13Z,16Z))	463	760	791	262	201	265	703	291	266	375
PC 38:1; [M-CH3]-; GPCho(18:0/20:1(11E))	1090	1650	1296	1290	962	881	786	843	440	752
PE 35:2; [M-H]-; GPEtn(17:0/18:2(2E,4E))	7002	7079	5803	3212	7159	6372	2259	4831	1564	3353
PC 35:1; [M-Ac-H]-; GPCho(17:0/18:1(11E))	7131	7981	8123	3864	5574	4845	4227	3514	4967	4872
PI 40:6; [M-H]-; GPIns(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	3908	5007	2597	2072	6579	2664	3226	5924	3469	3476
PE 41:6; [M-H]-; GPEtn(19:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	21610	23301	22724	10816	18907	8938	7659	9019	938	5918
PE 42:1; [M-H]-; GPEtn(18:1(11E)/24:0)	480	599	127	321	564	166	309	91	214	75
CL 70:4; [M-2H](2-); CL(16:0/18:1/18:2/18:1)	834	387	579	425	275	888	501	922	1397	644
PC 40:8; [M-Ac-H]-; GPCho(18:2(2E,4E)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	17360	28466	17450	12896	16866	16901	9357	9035	16379	7170
PC 33:1; [M-Ac-H]-; GPCho(16:0/17:1(9Z))	13559	17144	15192	5738	14048	5597	4879	6268	7876	5412
plasmenyl-PE 40:6; [M-H]-; PE(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	29680	21944	29182	8561	18230	22356	11215	15071	17394	13790
PC 34:0; [M+HCOO]-; GPCho(16:0/18:0)	4054	2735	3934	2661	3787	4892	2028	4009	3490	3934
PC 33:0; [M-Ac-H]-; GPCho(17:0/16:0)	10819	10949	13650	9356	10373	12029	10333	11144	9693	14539
PG 34:2; [M-H]-; GPGro(16:1(7Z)/18:1(11E))	256	378	742	72	104	109	95	190	85	237
PC 40:7; [M-Ac-H]-; GPCho(20:3(5Z,8Z,11Z)/20:4(5E,8E,11E,14E))	67955	113161	80381	42758	61006	44866	19188	46234	19406	25612
PC 37:4; [M-Ac-H]-; GPCho(17:0/20:4(5E,8E,11E,14E))	21692	39680	34261	15791	23216	13445	7257	13162	14367	9789
PC 23:0; [M-Ac-H]-; GPCho(7:0/16:0)	326	446	121	133	242	208	270	142	221	203
PA 38:2; [M-H]-; GPA(18:1(11E)/20:1(11E))	9926	8111	6889	3347	4784	4403	5997	3983	3067	7045
PS 36:4; [M-H]-; GPSer(16:0/20:4(5E,8E,11E,14E))	103	132	106	156	13	62	45	126	63	46
PC 34:3; [M-Ac-H]-; GPCho(16:0/18:3(6Z,9Z,12Z))	1333	598	1286	1218	788	1117	209	613	171	339
PC 38:3; [M-Ac-H]-; GPCho(18:2(2E,4E)/20:1(11E))	7564	9330	8629	8600	7680	6904	6516	9320	6679	6426
CL 78:11; [M-2H](2-); CL(16:0/18:0/22:5/22:6)	618	430	1112	311	183	413	281	393	249	541
PC 42:6; [M-Ac-H]-; GPCho(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	621	215	471	448	603	173	377	361	174	608
PE 33:1; [M-H]-; GPEtn(16:0/17:1(9Z))	230	418	913	440	444	385	302	289	133	200
CL 66:3; [M-2H](2-); CL(16:0/16:0/16:1/18:2)	594	315	265	297	241	213	426	198	133	180
PC 36:2; [M+HCOO]-; GPCho(16:0/20:2(11Z,14Z))	213	653	230	76	278	437	160	76	46	367
PC 40:1; [M-Ac-H]-; GPCho(16:0/24:1(15Z))	291	632	593	289	460	438	328	230	219	167
PE 40:3; [M-H]-; GPEtn(18:2(2E,4E)/22:1(13Z))	234	777	652	1890	703	1036	442	386	317	210
CL 72:2; [M-2H](2-); CL(18:1/18:0/20:1/16:0)	2357	2663	1528	1446	3254	2828	3160	1142	2150	525
PE 35:0; [M-H]-; GPEtn(17:0/18:0)	481	609	1059	677	679	345	777	181	393	489
PC 38:4; [M+HCOO]-; GPCho(16:0/22:4(7Z,10Z,13Z,16Z))	95	112	130	52	101	316	56	116	42	58
PE 37:2; [M-H]-; GPEtn(18:2(2E,4E)/19:0)	1323	1798	910	225	500	680	437	1041	250	496
plasmenyl-PE 40:4; [M-H]-; PE(P-20:0/20:4(5E,8E,11E,14E))	8735	9551	7096	5530	7050	7223	5522	4012	5302	5813
PC 35:2; [M-Ac-H]-; GPCho(17:0/18:2(2E,4E))	13117	11583	9621	4187	7788	3704	3501	3074	6660	2938
PE 34:1; [M-H]-; GPEtn(16:0/18:1(11E))	85121	74546	74853	22786	58688	32345	32318	24318	30080	33432
plasmenyl-PE 38:4; [M-H]-; PE(P-18:0/20:4(5E,8E,11E,14E))	2477	2959	1803	1128	870	1196	366	1574	1845	905
PA 34:0; [M-H]-; GPA(16:0/18:0)	203	350	464	169	521	330	35	169	188	170
PC 36:3; [M-CH3]-; GPCho(16:0/20:3(5Z,8Z,11Z))	58087	82013	68340	45265	47509	41269	39270	44246	34471	36261
PE 34:2; [M-H]-; GPEtn(16:0/18:2(2E,4E))	181102	195669	168739	82928	140566	87146	61950	68281	101338	72936
PC 38:7; [M-Ac-H]-; GPCho(18:3(6Z,9Z,12Z)/20:4(5E,8E,11E,14E))	22846	27165	18428	6821	18427	8237	7517	6906	6555	7304
CL 78:12; [M-2H](2-); CL(18:0/20:4/18:2/22:6)	22883	25064	19192	3508	16225	3925	1044	2266	5072	1793
CL 72:8; [M-2H](2-); CL(18:2/18:2/18:2/18:2)	263	185	156	251	178	94	162	157	109	165
PE 40:4; [M-H]-; GPEtn(18:0/22:4(7Z,10Z,13Z,16Z))	36656	62485	44531	21054	29463	22562	15916	19998	25847	18549
PC 30:0; [M+HCOO]-; GPCho(14:0/16:0)	299502	283920	313960	160259	281366	219624	153085	302439	312793	201895
PC 32:0; [M+HCOO]-; GPCho(16:0/16:0)	3241	3396	2512	1361	4717	2232	1676	1948	3069	1800
PE 36:2; [M-H]-; GPEtn(18:0/18:2(2E,4E))	233098	193867	200170	133829	187775	151360	162111	100881	166484	126556
PC 40:2; [M-Ac-H]-; GPCho(18:1(11E)/22:1(13Z))	3678	907	470	510	593	828	595	477	652	277
PC 40:6; [M+HCOO]-; GPCho(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	1940	3962	3222	1334	2088	1260	704	1337	1358	737
PC 30:1; [M-Ac-H]-; GPCho(14:0/16:1(7Z))	2599	1786	1624	557	1234	1098	581	959	1327	862
PC 37:3; [M-Ac-H]-; GPCho(17:0/20:3(5Z,8Z,11Z))	6305	12594	7697	3654	6966	3434	2877	4187	5161	3162
PC 37:1; [M-Ac-H]-; GPCho(18:1(11E)/19:0)	516	1850	667	272	602	885	535	440	361	441
CL 78:11; [M-2H](2-); CL(18:0/18:1/20:4/22:6)	257	1385	205	327	207	208	409	183	613	1217
PC 28:2; [M+HCOO]-; GPCho(2:0/26:2(5E,9Z))	314	483	238	367	308	469	299	238	197	245
PA 36:4; [M-H]-; GPA(16:0/20:4(5E,8E,11E,14E))	1762	1236	888	946	1102	1051	562	1119	350	1126
PG 34:0; [M-H]-; GPGro(17:0/17:0)	1464573	1700329	1772872	1373548	1540554	1943758	1533052	1915963	1877171	1801026
PC 40:6; [M-Ac-H]-; GPCho(20:2(11Z,14Z)/20:4(5E,8E,11E,14E))	46805	89755	45400	19746	36253	20405	12230	20958	22674	16346
PC 34:2; [M-Ac-H]-; GPCho(16:1(7Z)/18:1(11E))	26859	30202	25839	20180	24905	23133	19510	16331	18595	17745
PC 36:3; [M-CH3]-; GPCho(18:2(2E,4E)/18:1(11E))	790	560	580	504	671	293	278	257	93	437
CL 72:3; [M-2H](2-); CL(18:1/16:0/18:1/20:1)	51	98	134	21	15	96	34	108	144	80
PC 32:3; [M-Ac-H]-; GPCho(14:1(9Z)/18:2(2E,4E))	459	326	265	316	701	341	257	374	154	369
PE 44:4; [M-H]-; GPEtn(20:4(5E,8E,11E,14E)/24:0)	45	236	309	151	190	120	152	349	373	136
CL 68:2; [M-2H](2-); CL(16:0/16:0/18:1/18:1)	20489	16035	19131	8545	14724	7926	2948	6311	3251	10891
PC 34:3; [M-CH3]-; GPCho(16:1(7Z)/18:2(2E,4E))	12566	5041	9102	4814	7946	4839	2977	2081	3577	3286
PC 36:4; [M+HCOO]-; GPCho(18:2(2E,4E)/18:2(2E,4E))	43056	56669	48755	27341	39541	26256	15554	30632	24201	19420
PC 36:1; [M-CH3]-; GPCho(18:0/18:1(11E))	9130	9592	6220	5912	6407	9057	6161	5894	7319	5594
PE 38:1; [M-H]-; GPEtn(18:0/20:1(11E))	81	43	94	37	108	51	30	52	42	39
PC 38:2; [M-Ac-H]-; GPCho(18:2(2E,4E)/20:0)	75650	134701	135461	48160	85380	60360	59361	46158	54053	43544
CL 72:5; [M-2H](2-); CL(18:0/18:2/18:1/18:2)	1999	2977	1765	739	2305	1041	1047	1467	1637	1357
PC 38:6; [M+HCOO]-; GPCho(18:2(2E,4E)/20:4(5E,8E,11E,14E))	18443	34570	24593	15826	19503	15864	6550	15883	9818	12284
PC 23:1; [M-Ac-H]-; GPCho(5:0/18:1(11E))	2692	2681	2156	1880	2660	1173	2375	1901	1167	630
PG 38:3; [M-H]-; GPGro(18:1(11E)/20:2(11Z,14Z))	998	539	978	363	454	188	282	312	408	126
PG 38:5; [M-H]-; GPGro(18:2(2E,4E)/20:3(5Z,8Z,11Z))	210	248	221	155	119	226	364	51	299	98
PC 20:0; [M-Ac-H]-; GPCho(4:0/16:0)	572	333	487	341	201	226	526	541	391	299
CL 68:2; [M-2H](2-); CL(18:1/16:0/18:1/16:0)	26134	23848	23567	10732	13603	11454	4919	15354	7723	18042
PC 34:0 (internal standard)	117064	120133	132199	89531	99203	125395	73324	100016	113408	104954
PE 34:0 (internal standard)	949366	939269	993014	633575	803536	860805	565854	672554	876741	747916
PG 34:0 (internal standard)	1404773	1479536	1612508	1042058	1419264	1464629	1073084	1555279	1668868	1311933
PI 37:4 (internal standard)	315	479	215	154	679	313	210	132	111	58
PS 34:0 (internal standard)	90400	184036	123103	86293	82725	64543	37320	58022	54384	61437
CE 17:0; (internal standard)	95865	98460	104269	101688	75049	117555	124171	104274	102357	115173
lysoPC 17:0; (internal standard)	29907	50143	34000	26982	30402	54667	39456	54913	32663	26747
MG 17:0; (internal standard)	6377	3944	3297	6445	3370	6343	6531	4526	5488	2882
SM 17:0 (internal standard)	2102	2121	1955	879	1867	1092	1228	713	1101	1707
PA 17:0 (internal standard)	3556	962	1327	745	2419	833	2013	1434	1278	669
TG 17:0 (internal standard)	132	235	372	53	201	170	94	75	166	61
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name
PS 38:4; [M-H]-; GPSer(18:0/20:4(5E,8E,11E,14E))
PE 36:0; [M-H]-; GPEtn(17:0/19:0)
PE 40:6; [M-H]-; GPEtn(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE 38:6; [M-H]-; GPEtn(18:2(2E,4E)/20:4(5E,8E,11E,14E))
PS 40:6; [M-H]-; GPSer(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE 25:0; [M-H]-; GPEtn(7:0/18:0)
PE 21:0; [M-H]-; GPEtn(5:0/16:0)
PG 36:0; [M-H]-; GPGro(17:0/19:0)
PE 40:7; [M-H]-; GPEtn(18:1(11E)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE 40:4; [M-H]-; GPEtn(20:0/20:4(5E,8E,11E,14E))
CL 70:5; [M-2H](2-); CL(18:1/16:0/18:2/18:2)
PE 23:0; [M-H]-; GPEtn(7:0/16:0)
PE 38:6; [M-H]-; GPEtn(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
CL 70:5; [M-2H](2-); CL(18:1/16:1/18:1/18:2)
PE 40:2; [M-H]-; GPEtn(18:0/22:2(13Z,16Z))
PE 38:5; [M-H]-; GPEtn(18:0/20:5(5Z,8Z,11Z,14Z,17Z))
PE 38:2; [M-H]-; GPEtn(18:2(2E,4E)/20:0)
PE 33:0; [M-H]-; GPEtn(16:0/17:0)
MGDG 34:0; [M-H]-; MGDG(16:0/18:0)
PE 40:2; [M-H]-; GPEtn(18:1(11E)/22:1(13Z))
PE 42:10; [M-H]-; GPEtn(20:4(5E,8E,11E,14E)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE 36:0; [M-H]-; GPEtn(16:0/20:0)
PE 38:2; [M-H]-; GPEtn(18:1(11E)/20:1(11E))
PS 38:5; [M-H]-; GPSer(18:1(11E)/20:4(5E,8E,11E,14E))
CL 72:6; [M-2H](2-); CL(18:1/18:2/18:2/18:1)
PC 40:6; [M-CH3]-; GPCho(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE 24:0; [M-H]-; GPEtn(6:0/18:0)
PE 23:0; [M-H]-; GPEtn(5:0/18:0)
PC 38:6; [M-CH3]-; GPCho(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE 36:5; [M-H]-; GPEtn(16:0/20:5(5Z,8Z,11Z,14Z,17Z))
PE 40:7; [M-H]-; GPEtn(20:3(5Z,8Z,11Z)/20:4(5E,8E,11E,14E))
PE 34:2; [M-H]-; GPEtn(16:1(7Z)/18:1(11E))
PA 40:7; [M-H]-; GPA(18:1(11E)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PA 34:0; [M-H]-; GPA(17:0/17:0)
PI 36:2; [M-H]-; GPIns(18:0/18:2(2E,4E))
PG 38:6; [M-H]-; GPGro(18:2(2E,4E)/20:4(5E,8E,11E,14E))
CL 74:2; [M-2H](2-); CL(18:0/18:1/18:0/20:1)
PG 33:0; [M-H]-; GPGro(17:0/16:0)
PC 34:2; [M-Ac-H]-; GPCho(16:0/18:2(2E,4E))
PE 42:6; [M-H]-; GPEtn(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE 32:1; [M-H]-; GPEtn(16:0/16:1(7Z))
PE 22:0; [M-H]-; GPEtn(4:0/18:0)
PE 38:5; [M-H]-; GPEtn(18:1(11E)/20:4(5E,8E,11E,14E))
PG 38:5; [M-H]-; GPGro(18:1(11E)/20:4(5E,8E,11E,14E))
PC 36:4; [M-Ac-H]-; GPCho(16:0/20:4(5E,8E,11E,14E))
PG 32:1; [M-H]-; GPGro(16:0/16:1(7Z))
PC 34:3; [M-Ac-H]-; GPCho(16:1(7Z)/18:2(2E,4E))
PC 38:4; [M-CH3]-; GPCho(18:0/20:4(5E,8E,11E,14E))
PE 42:3; [M-H]-; GPEtn(18:2(2E,4E)/24:1(15Z))
PE 42:7; [M-H]-; GPEtn(20:1(11E)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PA 34:2; [M-H]-; GPA(16:0/18:2(2E,4E))
PE 42:2; [M-H]-; GPEtn(18:1(11E)/24:1(15Z))
CL 72:7; [M-2H](2-); CL(16:0/20:4/18:1/18:2)
PC 35:3; [M-Ac-H]-; GPCho(17:1(9Z)/18:2(2E,4E))
PC 38:6; [M-CH3]-; GPCho(18:2(2E,4E)/20:4(5E,8E,11E,14E))
PE 40:6; [M-H]-; GPEtn(18:1(11E)/22:5(4Z,7Z,10Z,13Z,16Z))
PC 21:0; [M-Ac-H]-; GPCho(5:0/16:0)
PC 32:1; [M-CH3]-; GPCho(16:0/16:1(7Z))
PG 38:4; [M-H]-; GPGro(18:1(11E)/20:3(5Z,8Z,11Z))
PC 25:0; [M+HCOO]-; GPCho(2:0/23:0)
PG 19:0; [M-H]-; GPGro(2:0/17:0)
PI 38:3; [M-H]-; GPIns(18:0/20:3(5Z,8Z,11Z))
PG 40:7; [M-H]-; GPGro(18:1(11E)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC 38:0; [M-Ac-H]-; GPCho(16:0/22:0)
PI 40:5; [M-H]-; GPIns(18:0/22:5(4Z,7Z,10Z,13Z,16Z))
PE 42:5; [M-H]-; GPEtn(20:4(5E,8E,11E,14E)/22:1(13Z))
CL 74:7; [M-2H](2-); CL(18:2/20:1/20:4/16:0)
PE 38:4; [M-H]-; GPEtn(18:0/20:4(5E,8E,11E,14E))
CL 70:4; [M-2H](2-); CL(16:0/18:1/18:1/18:2)
PE 42:4; [M-H]-; GPEtn(20:4(5E,8E,11E,14E)/22:0)
PE 42:7; [M-H]-; GPEtn(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC 36:2; [M-Ac-H]-; GPCho(18:0/18:2(2E,4E))
PC 32:1; [M-CH3]-; GPCho(16:1(7Z)/16:0)
CL 74:7; [M-2H](2-); CL(18:1/18:0/18:2/20:4)
plasmenyl-PE 36:5; [M-H]-; PE(P-16:0/20:5(5Z,8Z,11Z,14Z,17Z))
PE 36:4; [M-H]-; GPEtn(16:0/20:4(5E,8E,11E,14E))
PE 40:4; [M-H]-; GPEtn(16:0/24:4(5Z,8Z,11Z,14Z))
PI 38:4; [M-H]-; GPIns(18:0/20:4(5E,8E,11E,14E))
PE 37:1; [M-H]-; GPEtn(18:1(11E)/19:0)
PC 23:0; [M-Ac-H]-; GPCho(5:0/18:0)
PE 30:0; [M-H]-; GPEtn(14:0/16:0)
PC 38:2; [M-CH3]-; GPCho(20:1(11E)/18:1(11E))
PC 34:2; [M+HCOO]-; GPCho(16:1(7Z)/18:1(11E))
PC 38:4; [M-Ac-H]-; GPCho(18:0/20:4(5E,8E,11E,14E))
CL 68:3; [M-2H](2-); CL(16:0/16:0/18:1/18:2)
PE 33:2; [M-H]-; GPEtn(15:0/18:2(2E,4E))
PC 34:1; [M-Ac-H]-; GPCho(16:0/18:1(11E))
PC 22:0; [M-Ac-H]-; GPCho(6:0/16:0)
PG 34:3; [M-H]-; GPGro(16:1(7Z)/18:2(2E,4E))
PE 37:5; [M-H]-; GPEtn(17:1(9Z)/20:4(5E,8E,11E,14E))
CL 68:1; [M-2H](2-); CL(16:0/16:0/18:0/18:1)
PC 39:3; [M-Ac-H]-; GPCho(19:0/20:3(5Z,8Z,11Z))
PC 38:5; [M-CH3]-; GPCho(18:1(11E)/20:4(5E,8E,11E,14E))
PE 39:4; [M-H]-; GPEtn(19:0/20:4(5E,8E,11E,14E))
PE 40:5; [M-H]-; GPEtn(20:1(11E)/20:4(5E,8E,11E,14E))
PE 40:1; [M-H]-; GPEtn(18:0/22:1(13Z))
plasmenyl-PE 42:6; [M-H]-; PE(P-20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE 36:3; [M-H]-; GPEtn(18:1(11E)/18:2(2E,4E))
plasmenyl-PE 38:6; [M-H]-; PE(P-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PS 40:7; [M-H]-; GPSer(18:1(11E)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC 22:0; [M+HCOO]-; GPCho(6:0/16:0)
PE 38:5; [M-H]-; GPEtn(16:0/22:5(4Z,7Z,10Z,13Z,16Z))
PE 40:5; [M-H]-; GPEtn(18:0/22:5(4Z,7Z,10Z,13Z,16Z))
CL 68:4; [M-2H](2-); CL(16:0/18:2/16:1/18:1)
PC 26:0; [M-CH3]-; GPCho(16:0/10:0)
PE 34:3; [M-H]-; GPEtn(16:1(7Z)/18:2(2E,4E))
PE 36:5; [M-H]-; GPEtn(16:1(7Z)/20:4(5E,8E,11E,14E))
PE 38:4; [M-H]-; GPEtn(18:1(11E)/20:3(5Z,8Z,11Z))
PC 27:0; [M+HCOO]-; GPCho(2:0/25:0)
PE 35:1; [M-H]-; GPEtn(17:0/18:1(11E))
PG 36:2; [M-H]-; GPGro(18:0/18:2(2E,4E))
PC 38:6; [M+HCOO]-; GPCho(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC 40:3; [M-Ac-H]-; GPCho(20:0/20:3(5Z,8Z,11Z))
CL 72:6; [M-2H](2-); CL(18:1/18:2/18:1/18:2)
PC 42:10; [M-Ac-H]-; GPCho(20:4(5E,8E,11E,14E)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
CL 72:2; [M-2H](2-); CL(16:0/20:1/18:0/18:1)
CL 72:7; [M-2H](2-); CL(16:0/18:1/18:2/20:4)
PC 35:4; [M+HCOO]-; GPCho(15:0/20:4(5E,8E,11E,14E))
PE 38:7; [M-H]-; GPEtn(16:1(7Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC 40:7; [M-CH3]-; GPCho(18:1(11E)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC 36:4; [M-Ac-H]-; GPCho(18:2(2E,4E)/18:2(2E,4E))
PG 36:2; [M-H]-; GPGro(16:0/20:2(11Z,14Z))
PE 35:3; [M-H]-; GPEtn(17:1(9Z)/18:2(2E,4E))
PA 38:4; [M-H]-; GPA(18:0/20:4(5E,8E,11E,14E))
PC 30:0; [M-Ac-H]-; GPCho(14:0/16:0)
PC 36:2; [M-CH3]-; GPCho(18:0/18:2(2E,4E))
PC 36:5; [M-Ac-H]-; GPCho(16:1(7Z)/20:4(5E,8E,11E,14E))
DGDG 34:1; [M-H]-; DGDG(16:0/18:1(11E))
PE 35:4; [M-H]-; GPEtn(15:0/20:4(5E,8E,11E,14E))
PC 34:1; [M+HCOO]-; GPCho(16:0/18:1(11E))
PG 40:6; [M-H]-; GPGro(18:1(11E)/22:5(4Z,7Z,10Z,13Z,16Z))
DGDG 36:3; [M-H]-; DGDG(18:1(11E)/18:2(2E,4E))
MGDG 39:6; [M-H]-; MGDG(17:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PS 40:4; [M-H]-; GPSer(18:0/22:4(7Z,10Z,13Z,16Z))
PC 38:6; [M-Ac-H]-; GPCho(18:2(2E,4E)/20:4(5E,8E,11E,14E))
PE 37:4; [M-H]-; GPEtn(17:0/20:4(5E,8E,11E,14E))
PC 36:0; [M-Ac-H]-; GPCho(16:0/20:0)
PE 44:5; [M-H]-; GPEtn(20:4(5E,8E,11E,14E)/24:1(15Z))
CL 70:5; [M-2H](2-); CL(18:2/18:0/18:3/16:0)
PC 24:0; [M-Ac-H]-; GPCho(6:0/18:0)
PE 36:5; [M-H]-; GPEtn(18:2(2E,4E)/18:3(6Z,9Z,12Z))
PE 39:3; [M-H]-; GPEtn(19:0/20:3(5Z,8Z,11Z))
PC 38:3; [M-CH3]-; GPCho(18:0/20:3(5Z,8Z,11Z))
PC 35:2; [M-CH3]-; GPCho(17:0/18:2(2E,4E))
PC 36:4; [M-CH3]-; GPCho(16:0/20:4(5E,8E,11E,14E))
MGDG 40:6; [M-H]-; MGDG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC 32:0; [M-Ac-H]-; GPCho(15:0/17:0)
PE 41:4; [M-H]-; GPEtn(19:0/22:4(7Z,10Z,13Z,16Z))
PC 40:3; [M-Ac-H]-; GPCho(18:1(11E)/22:2(13Z,16Z))
PC 38:1; [M-CH3]-; GPCho(18:0/20:1(11E))
PE 35:2; [M-H]-; GPEtn(17:0/18:2(2E,4E))
PC 35:1; [M-Ac-H]-; GPCho(17:0/18:1(11E))
PI 40:6; [M-H]-; GPIns(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE 41:6; [M-H]-; GPEtn(19:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE 42:1; [M-H]-; GPEtn(18:1(11E)/24:0)
CL 70:4; [M-2H](2-); CL(16:0/18:1/18:2/18:1)
PC 40:8; [M-Ac-H]-; GPCho(18:2(2E,4E)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC 33:1; [M-Ac-H]-; GPCho(16:0/17:1(9Z))
plasmenyl-PE 40:6; [M-H]-; PE(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC 34:0; [M+HCOO]-; GPCho(16:0/18:0)
PC 33:0; [M-Ac-H]-; GPCho(17:0/16:0)
PG 34:2; [M-H]-; GPGro(16:1(7Z)/18:1(11E))
PC 40:7; [M-Ac-H]-; GPCho(20:3(5Z,8Z,11Z)/20:4(5E,8E,11E,14E))
PC 37:4; [M-Ac-H]-; GPCho(17:0/20:4(5E,8E,11E,14E))
PC 23:0; [M-Ac-H]-; GPCho(7:0/16:0)
PA 38:2; [M-H]-; GPA(18:1(11E)/20:1(11E))
PS 36:4; [M-H]-; GPSer(16:0/20:4(5E,8E,11E,14E))
PC 34:3; [M-Ac-H]-; GPCho(16:0/18:3(6Z,9Z,12Z))
PC 38:3; [M-Ac-H]-; GPCho(18:2(2E,4E)/20:1(11E))
CL 78:11; [M-2H](2-); CL(16:0/18:0/22:5/22:6)
PC 42:6; [M-Ac-H]-; GPCho(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE 33:1; [M-H]-; GPEtn(16:0/17:1(9Z))
CL 66:3; [M-2H](2-); CL(16:0/16:0/16:1/18:2)
PC 36:2; [M+HCOO]-; GPCho(16:0/20:2(11Z,14Z))
PC 40:1; [M-Ac-H]-; GPCho(16:0/24:1(15Z))
PE 40:3; [M-H]-; GPEtn(18:2(2E,4E)/22:1(13Z))
CL 72:2; [M-2H](2-); CL(18:1/18:0/20:1/16:0)
PE 35:0; [M-H]-; GPEtn(17:0/18:0)
PC 38:4; [M+HCOO]-; GPCho(16:0/22:4(7Z,10Z,13Z,16Z))
PE 37:2; [M-H]-; GPEtn(18:2(2E,4E)/19:0)
plasmenyl-PE 40:4; [M-H]-; PE(P-20:0/20:4(5E,8E,11E,14E))
PC 35:2; [M-Ac-H]-; GPCho(17:0/18:2(2E,4E))
PE 34:1; [M-H]-; GPEtn(16:0/18:1(11E))
plasmenyl-PE 38:4; [M-H]-; PE(P-18:0/20:4(5E,8E,11E,14E))
PA 34:0; [M-H]-; GPA(16:0/18:0)
PC 36:3; [M-CH3]-; GPCho(16:0/20:3(5Z,8Z,11Z))
PE 34:2; [M-H]-; GPEtn(16:0/18:2(2E,4E))
PC 38:7; [M-Ac-H]-; GPCho(18:3(6Z,9Z,12Z)/20:4(5E,8E,11E,14E))
CL 78:12; [M-2H](2-); CL(18:0/20:4/18:2/22:6)
CL 72:8; [M-2H](2-); CL(18:2/18:2/18:2/18:2)
PE 40:4; [M-H]-; GPEtn(18:0/22:4(7Z,10Z,13Z,16Z))
PC 30:0; [M+HCOO]-; GPCho(14:0/16:0)
PC 32:0; [M+HCOO]-; GPCho(16:0/16:0)
PE 36:2; [M-H]-; GPEtn(18:0/18:2(2E,4E))
PC 40:2; [M-Ac-H]-; GPCho(18:1(11E)/22:1(13Z))
PC 40:6; [M+HCOO]-; GPCho(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC 30:1; [M-Ac-H]-; GPCho(14:0/16:1(7Z))
PC 37:3; [M-Ac-H]-; GPCho(17:0/20:3(5Z,8Z,11Z))
PC 37:1; [M-Ac-H]-; GPCho(18:1(11E)/19:0)
CL 78:11; [M-2H](2-); CL(18:0/18:1/20:4/22:6)
PC 28:2; [M+HCOO]-; GPCho(2:0/26:2(5E,9Z))
PA 36:4; [M-H]-; GPA(16:0/20:4(5E,8E,11E,14E))
PG 34:0; [M-H]-; GPGro(17:0/17:0)
PC 40:6; [M-Ac-H]-; GPCho(20:2(11Z,14Z)/20:4(5E,8E,11E,14E))
PC 34:2; [M-Ac-H]-; GPCho(16:1(7Z)/18:1(11E))
PC 36:3; [M-CH3]-; GPCho(18:2(2E,4E)/18:1(11E))
CL 72:3; [M-2H](2-); CL(18:1/16:0/18:1/20:1)
PC 32:3; [M-Ac-H]-; GPCho(14:1(9Z)/18:2(2E,4E))
PE 44:4; [M-H]-; GPEtn(20:4(5E,8E,11E,14E)/24:0)
CL 68:2; [M-2H](2-); CL(16:0/16:0/18:1/18:1)
PC 34:3; [M-CH3]-; GPCho(16:1(7Z)/18:2(2E,4E))
PC 36:4; [M+HCOO]-; GPCho(18:2(2E,4E)/18:2(2E,4E))
PC 36:1; [M-CH3]-; GPCho(18:0/18:1(11E))
PE 38:1; [M-H]-; GPEtn(18:0/20:1(11E))
PC 38:2; [M-Ac-H]-; GPCho(18:2(2E,4E)/20:0)
CL 72:5; [M-2H](2-); CL(18:0/18:2/18:1/18:2)
PC 38:6; [M+HCOO]-; GPCho(18:2(2E,4E)/20:4(5E,8E,11E,14E))
PC 23:1; [M-Ac-H]-; GPCho(5:0/18:1(11E))
PG 38:3; [M-H]-; GPGro(18:1(11E)/20:2(11Z,14Z))
PG 38:5; [M-H]-; GPGro(18:2(2E,4E)/20:3(5Z,8Z,11Z))
PC 20:0; [M-Ac-H]-; GPCho(4:0/16:0)
CL 68:2; [M-2H](2-); CL(18:1/16:0/18:1/16:0)
PC 34:0 (internal standard)
PE 34:0 (internal standard)
PG 34:0 (internal standard)
PI 37:4 (internal standard)
PS 34:0 (internal standard)
CE 17:0; (internal standard)
lysoPC 17:0; (internal standard)
MG 17:0; (internal standard)
SM 17:0 (internal standard)
PA 17:0 (internal standard)
TG 17:0 (internal standard)
METABOLITES_END
#END